Accepted for/Published in: JMIR Research Protocols
Date Submitted: Mar 14, 2022
Date Accepted: Apr 30, 2022
Analysis of Mesh-Tissue Integration on Platelet-Rich Plasma-Decellularized Amnion Scaffold Sandwich on Polypropylene Mesh Implanted in Vesicovaginal Space of Hypoestrogenic Rabbit Model: A Research Protocol
ABSTRACT
Background:
Mesh-augmented surgery with polypropylene mesh (PPM) is often used in urogynecology and pelvic reconstructive surgery. However, various complications arising from its integration process cause a decrease in number of mesh-augmented surgery performed worldwide. An approach to improve mesh-tissue integration is by coating PPM with anti-inflammatory and wound healing molecules such as platelet-rich plasma (PRP) which is part of biotechnologies capable of accelerating wound healing. Estrogen is also known to have beneficial effect in wound remodelling, therefore hypoestrogenic status may have negative implication on wound healing. The mechanism of how PRP play a role in wound remodelling especially in hypoestrogenic state has not been fully described until now.
Objective:
The aim is to investigate the impact of platelet-rich plasma application to polypropylene mesh in hypoestrogenic rabbits model.
Methods:
This is a randomized controlled trial on hypoestrogenic rabbit model. Samples were categorized into either PRP or PPM groups (1:1 ratio) with a minimum sample size of 16 in each arm using simple random sampling. All samples were put into hypoestrogenic state by bilateral oophorectomy. After confirming the decrease of estradiol level, the mesh was implanted in vesicovaginal space. The samples were euthanized on either the 7th, 14th, 28th, or 90th day of the surgery. The mesh-tissue integration process will be measured by inflammatory parameters (ININ, IL-17, and IL-1b expression), angiogenesis (CD-31 expression) and collagen deposition will be assessed using Masson’s Trichrome staining.
Results:
This study is at the protocol development stage. A preliminary study regarding its feasibility, including preparation of hypoestrogenic rabbit model, mesh implantation in the rabbit's vesicovaginal space, PRP and amnion scaffold, has started since February 2022. The results of this study are expected to be available by the end of 2022.
Conclusions:
This randomized controlled trial is designed to provide high-quality evidence on the effect of platelet-rich plasma-decellurized amnion scaffold application to polypropylene mesh in vesicovaginal space of the hypoestrogenic rabbit model.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.